EpCAM Expression in Retinoblastoma: A Novel Molecular Target for Therapy-Reference-Cited by-同舟云学术

EpCAM Expression in Retinoblastoma: A Novel Molecular Target for Therapy

Published:2004-12-01 Issue:12 Volume:45 Page:4247
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Krishnakumar Subramanian¹,Mohan Adithi¹,Mallikarjuna Kandalam¹,Venkatesan Nalini¹,Biswas Jyotirmay¹,Shanmugam Mahesh Palanivelu²,Ren-Heidenreich Lifen³

Affiliation:

1. From the Department of Ocular Pathology, Vision Research Foundation, Sankara Nethralaya, Chennai, India; the

2. Department of Ocular Oncology, Medical Research Foundation, Sankara Nethralaya, Chennai, India; and the

3. Molecular Immunology Laboratory, Adele R. DeCof Cancer Center, Roger Williams Hospital, Providence, Rhode Island.

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress of Cancer Stem Cells in Retinoblastoma;Current Stem Cell Research & Therapy;2023-10-06

2. Nanoparticle-based delivery systems as emerging therapy in retinoblastoma: recent advances, challenges and prospects;Nanoscale Advances;2023

3. Immunotherapy for Ocular Tumors;Handbook of Cancer and Immunology;2023

4. Retinoblastoma cell-derived Twist protein promotes regulatory T cell development;Cancer Immunology, Immunotherapy;2020-10-27

5. Proof of concept: anti-EPCAM gold nanorods and femtosecond laser pulses for retinoblastoma treatment;Biophotonics: Photonic Solutions for Better Health Care VI;2018-05-17